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STUDY QUESTION: Is there a relation between ART and DNA methylation (DNAm) patterns in cord blood, including any differences
between IVF and ICSI?
SUMMARY ANSWER: DNAm at 19 CpGs was associated with conception via ART, with no difference found between IVF and ICSI.
WHAT IS KNOWN ALREADY: Prior studies on either IVF or ICSI show conflicting outcomes, as both widespread effects on DNAm
and highly localized associations have been reported. No study on both IVF and ICSI and genome-wide neonatal DNAm has been
performed.
STUDY DESIGN, SIZE, DURATION: This was a cross-sectional study comprising 87 infants conceived with IVF or ICSI and 70 con-
ceived following medically unassisted conception. The requirement for inclusion in the study was an understanding of the Swedish language
and exclusion was the use of donor gametes.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were from the UppstART study, which was recruited from
fertility and reproductive health clinics, and the Born into Life cohort, which is recruited from the larger LifeGene study. We measured
DNAm from DNA extracted from cord blood collected at birth using a micro-array (450k array). Group differences in DNAm at individual
CpG dinucleotides (CpGs) were determined using robust linear models and post-hoc Tukey’s tests.
MAIN RESULTS AND THE ROLE OF CHANCE: We found no association of ART conception with global methylation levels,
imprinted loci and meta-stable epialleles. In contrast, we identify 19 CpGs at which DNAm was associated with being conceived via ART
(effect estimates: 0.5–4.9%, PFDR < 0.05), but no difference was found between IVF and ICSI. The associated CpGs map to genes related
to brain function/development or genes connected to the plethora of conditions linked to subfertility, but functional annotation did not
point to any likely functional consequences.
LIMITATIONS, REASONS FOR CAUTION: We measured DNAm in cord blood and not at later ages or in other tissues. Given the
number of tests performed, our study power is limited and the findings need to be replicated in an independent study.
WIDER IMPLICATIONS OF THE FINDINGS: We find that ART is associated with DNAm differences in cord blood when compared
to non-ART samples, but these differences are limited in number and effect size and have unknown functional consequences in adult
blood. We did not find indications of differences between IVF and ICSI.
VC The Author(s) 2020. Published by Oxford University Press on behalf of European Society of Human Reproduction and Embryology.
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Introduction
The usage of ART is increasing worldwide and its possible health con-
sequences are a topic of intense study. Evidence is building for an as-
sociation of ART with long-term health outcomes for the offspring,
including autism spectrum disorders (Liu et al., 2017) and cardiovascu-
lar health (higher blood pressure, suboptimal cardiac diastolic function
and vessel thickness) (Guo et al., 2017). A body of evidence links ART
to short-term health effects, including low birthweight, placenta-
associated anomalies (Vermey et al., 2019), pregnancy complications
(Qin et al., 2016) and congenital malformations and imprinting disor-
ders (Turkgeldi et al., 2016). However, it is still debated if these associ-
ations stem from the application of ART or the underlying infertility
leading couples to ART (Luke et al., 2016). Animal studies have pro-
vided potential molecular mechanisms for these observations by
highlighting that the ART procedure may induce changes to epigenetic
marks (Morgan et al., 2008; Wang et al., 2010). Epigenetic marks, such
as DNA methylation (DNAm), influence the transcription potential of
genomic regions (Jaenisch and Bird, 2003). Human studies likewise
point toward a link between early development, DNAm and (late-life)
phenotypes, but the causality of these associations remains unknown
(Tobi et al., 2018).
To date, several studies on DNAm and ART have been performed.
Multiple studies have focused on candidate gene regions and/or global
methylation levels (Lazaraviciute et al., 2014; Canovas et al., 2017).
Genome-wide efforts have focused on samples taken from extra-
embryonic lineages (Xu et al., 2017; Choufani et al., 2019) and when
focused on material from the infant itself suffered from a small sample
size (Melamed et al., 2015) or batch effects correlating with ART sta-
tus (Estill et al., 2016). Larger studies have focused on specific ART
techniques, namely ICSI (El Hajj et al., 2017) or IVF (Castillo-
Fernandez et al., 2017) or IVF and the less invasive gamete intra-
fallopian transfer (GIFT) coupled with IUI (Novakovic et al., 2019). It
has been hypothesized that the technique used may matter for the
possible consequences on DNAm patterns (Loke and Craig, 2016).
Overall, these studies report conflicting outcomes, with two reporting
widespread associations between ART and (cord) blood DNAm at
birth (El Hajj et al., 2017), which appear to fade with age (Novakovic
et al., 2019), while another study reported a DNAm difference at a
single genomic locus only (Castillo-Fernandez et al., 2017).
We undertook an epigenome-wide association study (EWAS) on
ART, comparing DNAm patterns in cord blood of children conceived
via ART (N¼ 87) (Iliadou et al., 2019) with that of children from
medically unassisted conceptions (MUC, N¼ 70) (Almqvist et al.,
2011). Since we had detailed information on the ART technique used
for 77 of the children conceived via ART, we investigated possible dif-
ferent outcomes for IVF and ICSI on DNAm, which has been hypothe-
sized to be important (Loke and Craig, 2016), but is yet to be tested.
In addition, we explored the possible functional consequences of
methylation differences using external datasets.
Materials and methods
Study subjects
ART controls: Born into Life
Study participants in the prospective longitudinal birth cohort study
Born into Life were recruited from the larger LifeGene study (Almqvist
et al., 2011). LifeGene is a prospective cohort study with the aim to
combine advances in modern biotechnology with information on indi-
viduals’ health and lifestyle collected through web-based questionnaires
and biosamples. Recruitment of LifeGene participants aged
18–45 years was based on random sampling in the general population
and they were invited to include their adult household members.
Between the years 2010 and 2012, pregnant women who were al-
ready participating in the LifeGene study and living in Stockholm
County were recruited to Born into Life (Smew et al., 2018). The in-
clusion criteria for Born into Life were that the women had responded
to baseline questionnaires from the LifeGene study, were pregnant
and gave written informed consent. They were recruited both before
and after 10–14 gestational weeks, but no later than 26–28 weeks.
Originally, 107 pregnant women were included in Born into Life. We
only included the 77 women for which cord blood had been success-
fully collected in this study.
Women in the Born into Life were asked to complete
questionnaires regarding pregnancy, lifestyle and health at 10–14 and
26–28 gestational weeks. Data on maternal self-reported smoking dur-
ing pregnancy and BMI (kg/m2) obtained at the first antenatal care visit
in gestational weeks of 5–12 were collected from birth records. Data
regarding highest attained educational level, ranging from mandatory
secondary school to high school, university or other, were retrieved
from the baseline LifeGene questionnaires. Maternal age at delivery, in
years, was calculated from mothers’ date of birth. Parity and data re-
garding the infants’ sex, gestational age in weeks and mode of delivery,
defined as vaginal delivery or cesarean section, were also collected































































































from the birth records. Cord blood and placenta samples were
obtained from delivery. Cord blood was aspirated 2 min after birth by
the assisting midwife into a test tube (EDTA) and kept at room tem-
perature while awaiting transportation. The birth records regarding
both mother and child at delivery were collected from Danderyd
Hospital, Stockholm.
ART cases: UppstART
The UppstART study has been described in detail elsewhere (Iliadou
et al., 2019). Participants of the UppstART study were recruited from
three of the four fertility and reproductive health clinics in Stockholm
(one public, two private) and one private clinic in Uppsala county,
which also serves a large volume of patients from Stockholm.
Recruitment took place from September 2011 to December 2013.
IVF treatment(s) of the participants was followed until December
2014 or drop-out/consent withdrawn (n¼ 4), whichever came first.
The participants were asked to answer a web-based baseline question-
naire within a few days of their clinic visit and prior to their IVF treat-
ment start, which included an extensive list of questions on
sociodemographic, anthropometric and lifestyle factors. Once the IVF
treatment began and the participants reached the stage of oocyte re-
trieval, they were asked to respond to a second online follow-up ques-
tionnaire, with a shorter version of the baseline questionnaire, to
identify any changes in lifestyle factors since the initiation of their treat-
ment. Staff at seven delivery units in Stockholm and Uppsala were
recruited to assist in collecting samples from UppStART participants
during delivery. Delivery clinics were provided with a sample collection
kit including tubes for collection of cord blood for DNA extraction
(EDTA). Samples were stored in 20C freezers at the delivery units
until they were collected by UppStART study staff and deposited into
the KI Biobank.
DNAm measurements
Genome-wide DNAm data were generated using the Illumina Infinium
Human Methylation 450K BeadChip (450k array). A total of 500 ng of
genomic DNA isolated from cord blood was bisulfite treated using the
EZ-96 DNA methylation kit (Zymo Research, Orange County, CA,
USA). We used the D-optimum criterion to assign samples over two
96-well plates and individual 450k arrays, ensuring even distributions of
ART cases and controls, ART methods (IVF or ICSI), sex, gestational
age and birth month across the two 96-well bisulfite plates and each
450k array. The 450K arrays were measured at ServiceXS (Leiden,
The Netherlands). The quality of the generated 450K array data was
assessed using both sample dependent and sample independent quality
metrics using the Bioconductor package MethylAid (van Iterson et al.,
2014) with default settings. We used the Bioconductor package
omicsPrint (van Iterson et al., 2018) to check for sample duplications
and mixtures, the absence of family relations and to identify the
probes where single nucleotide polymorphisms (SNPs) influence the
measurement of the methylated or unmethylated signal (Zhou et al.,
2017). These probes were kept as, although not our main interest,
any difference in those probes might hint at interesting genetic differen-
ces. Sample sexes were checked using the X-chromosomal CpGs.
One sample was not the correct sex and was deleted. We used prin-
cipal component analysis (PCA) and hierarchical clustering on the raw
autosomal beta values to search for outliers and suspect patterns in
the dataset, finding none. The cell proportions of cord blood were im-
puted using the “Identifying Optimal Libraries” (IDOL) algorithm
(Koestler et al., 2016) on the ‘FlowSorted.CordBloodCombined.450k’
reference set using the estimateCellCounts2() function in the
FlowSorted.Blood.EPIC R package (Salas et al., 2018; Gervin et al.,
2019). Normalization of the dataset was performed by NOOB back-
ground and color correction in combination with Functional
Normalization (Fortin et al., 2014) using four principal components (ei-
genvalue >1). All measurements with <3 beads (0.05% of probes),
<1 intensity value (0.012% of probes) and a detection P-value >0.01
(0.11% of CpGs) were set as missing. The measurement success rate
per sample was >99%. CpGs with probes that did not map to unique
genomic locations (Chen et al., 2013) or with a <95% measurement
success rate (0.23% of CpGs) were then removed. We used custom
scripts that add on the functions from the minfi package (Aryee et al.,
2014) and implements parallelization where possible (https://github.
com/molepi/DNAmArray).
Outlier detection was performed by PCA and hierarchical clustering
on the autosomal beta values. Hierarchical clustering identified one
possible outlier. This individual had a very low gestational age
(30 weeks), the lowest in the dataset, and this clustering is therefore
likely based on biological reasons. High-quality DNAm data were
obtained for 157 individuals, including 70 MUC from Born into Life, six
ART from Born into Life (specific type of ART unknown) and 81 ART
from UppStART (specific type of ART unknown for N¼ 4), for a total
of 441 836 autosomal CpGs. The datasets generated and analyzed
during the current study are not publicly available due to Swedish pri-
vacy and data safety laws but are available from A.N.I. and C.A. on
reasonable request and after meeting legal requirements.
Measures of global methylation
Genome-wide average DNA methylation (GWAM) (Li et al., 2018)
was calculated by averaging all beta-value measurements across the
autosomes for each individual. The R package REMP (Zheng et al.,
2017) was used to infer DNAm at either ALU or LINES-1 sequences
and then the average across all ALU or LINES-1 elements was calcu-
lated for each neonate.
Transcription factor binding site
enrichment
We calculated transcription factor binding site (TFBS) enrichments us-
ing the R package PWMEnrich (Stojnic and Diez, 2018) and using bind-
ing motifs from motifDB. We calculated position weight matrices using
the DNA base background frequencies calculated for the CpGs tested
with 25 bp flanking sequences. Enrichment was tested relative to this
background.
Statistics
We compared MUC and ART cohort descriptives via Kruskal–Wallis
(maternal BMI, maternal socio-economic status (SES), years until index
pregnancy, CD4T, natural killer (NK) and nucleated red blood cells:
nRBC), Student’s t-test (maternal and gestational age, birthweight,
CD8T, monocytes (mono), granulocytes (gran) and B cell (Bcell) pro-
portions) assuming equal or unequal variance, where appropriate, and
chi-square tests (child sex, parity, preterm births and maternal































































































smoking). DNAm was always analyzed as a beta value, which is
reported as a percentage (e.g. 100). GWAM, ALU and LINES-1
methylation levels were compared via t-test (MUC versus ART) or
ANOVA (MUC versus IVF versus ICSI).
We used the R package cate (Wang and Zhao, 2015) to identify la-
tent variables (e.g. ‘hidden variables’) influencing the relation between
DNAm and ART (yes/no) or ART method (IVF/ICSI/MUC). Two la-
tent variables were identified (P< 0.001) for ART and four latent vari-
ables for ART method (P< 0.001). In both cases, the first two latent
variables correlated with the proportion of nRBC in blood (rho> 0.94,
P< 0.001) and the other two latent variables correlated with CD4T
or B cell proportions in blood and several batch effects (rho > 0.3,
P< 0.001) arguing, together with directed acyclic graphs (DAG)
(Supplementary Data), for a basic model adjusting for batch effects
and imputed cell proportions.
We performed EWAS on being conceived by ART or not using ro-
bust linear regression (rlm) from the R MASS package with White’s es-
timator for robust standard errors, as implemented in the R package
sandwich (Zeileis, 2006) (which leads to a model robust for outlying
beta values and heteroscedasticity). To test for differences in neonates
conceived via IVF or ICSI or without medical assistance (MUC), we
used type II ANOVA with White’s estimator for robust standard
errors to account for any heteroscedasticity and unequal variances be-
tween groups using the R car package. We employed heteroscedastic-
ity robust Tukey’s tests to test for DNAm differences between IVF,
ICSI and MUC post-hoc. In all instances, we used the beta value of an
individual CpG dinucleotide as the outcome and ART status as the de-
pendent. We adjusted for the sex of the individual, height of the sam-
ple on the 450k array glass slide (coded as a continuous variable from
1 to 6), scan batch and bisulfite plate and the imputed cell proportions
(CD4T, CD8T, Mono, NK, Bcell, Gran, nRBC). We ran additional
sensitivity analyses by omitting the cell proportions or expanding the
adjustment with minimal adjustment sets coming from DAG analysis
(Supplementary Data) with the following models: years until the index
pregnancy, maternal age, pre-pregnancy BMI, educational attainment
as proxy for SES, smoking history, and gestational length and parity. In
addition, we performed look-ups in other published meta-EWAS of
prenatal exposures.
Regions were tested with the same adjustments as defined above in
a linear mixed model with a random effect for individual and a factorial
covariate denoting the specific CpG dinucleotide of each DNAm mea-
surement in the R lme4 package using compound symmetry as correla-
tion structure and the R lmerTest package for the Satterthwaite’s
approximation of the degree of freedom of the fixed effects within
each linear mixed model.
All analyses were performed in R (version 3.6.1) (R Core Team,
2019). All P-values reported are two-sided and multiple testing correc-
tion is done using false discovery rate (FDR).
Ethical approval
Ethical approval for Born into Life was granted by the Regional Ethics
Review Board in Stockholm, Sweden. Written informed consent from
both parents was obtained for all study participants. The UppstART
study has been approved by the regional ethics review board at the
Karolinska Institutet (Dnr 2011/230-31/1, Dnr 2011/1427-32, Dnr
2012/131-32, Dnr 2012/792-32, 2013/1700-32, 2014/1956-32, Dnr
2015/1604-32). Women and their partners were approached by the
clinic nurse and asked to participate in the study. To facilitate the pro-
cess of informed consent, the couple was provided with information
approved by the regional ethical board, both verbally and in written
format, about the purpose of the study, methods, possible risks, and
that participation was voluntary. Additionally, participants were in-
formed that they could withdraw from the study at any time with no
impact to their medical care. The requirement for inclusion in the
study was an understanding of the Swedish language and exclusion was
the use of donor gametes.
Results
Study subjects
Pre-processing and normalization resulted in DNAm data of 157
infants from cord blood, 87 of which were conceived with the help of
ART (Table I). We had detailed information on the ART technique
used for 77 of the 87 newborns conceived by ART and with DNAm
data, of which 44 were conceived via IVF and 33 via ICSI. The moth-
ers who conceived with the help of ART were not different in terms
of BMI (P¼ 0.25) and age (P¼ 0.25), but had a lower SES (P< 0.001)
and more were former smokers (P< 0.001) than mothers with a
MUC. It took on average 2 years longer for the mothers who con-
ceived through ART to become pregnant than for mothers with MUC
(P< 0.001). There was no difference between ART and MUC in
length of gestation (P¼ 0.16) and parity (P¼ 0.20). The percentage of
male newborns in the MUC group was higher (61.4% versus 50.6%),
although this difference was not significant (P¼ 0.23).
DNAm is a key determinant of cell identity (Jaenisch and Bird,
2003) and cord blood consists of multiple cell types that influence
DNAm variation. Seven major cell types, including nRBCs, were im-
puted from the genome-wide DNAm data of the newborns (Gervin
et al., 2019). In concordance with a prior report on unassisted and
ICSI newborns (El Hajj et al., 2017), there were no differences in these
seven cell proportions between ART and MUC cord blood samples
(Pnominal > 0.13, Supplementary Fig. S1).
Global DNAm comparison between ART
and unassisted conceptions
First, we investigated GWAM (Li et al., 2018) in the cord blood
of neonates conceived via IVF, ICSI or MUC. There was no differ-
ence between these three groups (P¼ 0.89, Supplementary Fig.
S2). Next, we investigated the average methylation of ALU and
LINES-1 elements, an often used proxy for global DNAm (Zheng
et al., 2017), finding no difference between groups (P> 0.2,
Supplementary Fig. S3).
DNAm comparison between ART and MUC
We compared DNAm at 441 836 autosomal CpGs between 87 ART
and 70 MUC neonates (Supplementary Fig. S4). Nineteen CpGs were
associated with being conceived via ART in a model adjusting for sex,
batches and cell heterogeneity (PFDR < 0.05, Table II, Supplementary
Fig. S5). The mean absolute differences between MUC and ART are
small from a molecular point of view (b¼ 0.48–4.89%), and medium










































to large when looked at in terms of effect size (0.44–1.00 SD), which
is similar to that found for other prenatal exposures such as prenatal
smoking (Joubert et al., 2016b), folate use (Joubert et al., 2016a), fam-
ine (Tobi et al., 2018) and hypertension and pre-eclampsia (Kazmi
et al., 2019). The associations extended to neighboring probes (Fig. 1)
for the proximal promoter of AK054845, a gene of unknown function
(five CpGs Pnominal < 0.05), and the proximal promoter of a smaller
variant of GABRB3 (NM_001191321.2), which is expressed in the brain
(eight CpGs Pnominal < 0.05) and has a neuro-developmental role
(Tanaka et al., 2012).
Omitting the adjustment for cell heterogeneity had little to no in-
fluence on the effect estimates for all 19 CpGs (Supplementary
Table SI) just like additional adjustment for maternal and pregnancy
characteristics (Supplementary Table SII) or exclusion of the neo-
nates of which the embryo was frozen and/or transferred as a blas-
tocyst (Supplementary Table SIII). The 19 CpGs were not among
those previously reported in other EWASs (FDR corrected P-value
of <0.05) with prenatal smoking (Joubert et al., 2016b), folate use
(Joubert et al., 2016a), maternal hypertension and pre-eclampsia
(Kazmi et al., 2019), maternal BMI (Sharp et al., 2017) and birth-
weight (Küpers et al., 2019). Moreover, a look-up of these previ-
ously reported CpGs in our study did not yield more nominally
associated CpGs with ART than may be expected by chance
(P> 0.07).
DNAm comparison between IVF, ICSI and
MUC
To investigate any differences between IVF and ICSI, we performed
post-hoc Tukey’s tests for DNAm differences between neonates con-
ceived via IVF and ICSI for these 19 CpGs. No differences were found
(PFDR-19 tests > 0.15). Next, we extended our analysis to all CpGs by
performing an ANOVA analysis to test for differences in DNAm
across the 441 836 autosomal CpGs between neonates conceived
with IVF (N¼ 44), ICSI (N¼ 33) or MUC (N¼ 70). This yielded five
CpGs already identified in the EWAS for ART status and in all cases, a
post-hoc Tukey’s test showed that there was a DNAm difference for
all five CpGs for both the MUC versus IVF and MUC versus ICSI com-
parison, thus finding no evidence for IVF or ICSI specific associations.
Functional annotation
We performed KEGG and Gene Ontology tests (Phipson et al., 2016),
finding no enrichment for the genes linked to the 19 CpGs associated
with ART, nor when we relaxed the significance threshold to
............................................................................................................................................................................................................................
Table I Characteristics of the cohorts in a study of DNAm and ART.
Variable MUC ART P-value IVF ICSI
N 70 87 44 33
N frozen1 – 10 7 3
N blastocyst (N frozen)2 – 8 5 (3 frozen) 3 (2 frozen)
BMI in kg/m2 (SD) 22.8 (3.5) 23.4 (3.4) 0.25 23.5 (3.3) 23.4 (3.0)
Age in years (SD) 32.4 (3.6) 33.1 (3.6) 0.25 33.0 (3.7) 33.0 (3.7)
SES3 (SD) 3.0 (0.3) 2.6 (0.8) <0.001* 2.7 (0.7) 2.3 (0.9)
Smoking (%) <0.001*
Never 65 (92.8) 56 (64.4) 27 (61.4) 23 (69.7)
Ever 4 (5.8) 26 (29.9) 17 (38.6) 9 (27.3)
NA 1 (1.4) 5 (5.7) 0 (0.0) 1 (3.0)
Years to index pregnancy <0.001*
Mean (SD) 0.2 (0.7) 2.6 (1.3) 2.7 (1.2) 2.4 (1.5)
Min.–max. 0–4 0–7 1–7 0–7
Parity (%) 0.20
First 47 (67.1) 62 (71.4) 34 (77.3) 22 (66.7)
Second 21 (30.0) 17 (19.5) 10 (22.7) 7 (21.2)
Third 2 (2.9) 1 (1.1) 0 (0.0) 1 (3.0)
NA 0 (0.0) 7 (8.0) 0 (0.0) 3 (9.1)
N male children (%) 43 (61.4) 44 (50.6) 0.23 22 (50.0) 16 (48.5)
Gestational age in weeks 39.1 (1.6) 39.5 (2.0) 0.16 39.2 (2.3) 39.7 (1.6)
N preterm births4 3 3 0.99 3 0
1The number of embryos that were frozen and thawed before placement in utero.
2The number of embryos that were cultured in vitro to the blastocyst stage before placement in utero. Five of these blastocysts were frozen and thawed.
3SES graded on a four-level scale based on the highest attained educational level.
4Number of infants born preterm (gestational age of <36 weeks).
*P< 0.001 in a comparison between ART and MUC using Kruskal–Wallis (SES, years until index pregnancy) and chi-square (maternal smoking) tests.
DNAm, DNA methylation; MUC, medically unassisted conception; SES, socio-economic status.









































suggestive associations (P< 105, N¼ 37). We did not find significant
enrichments of single transcription factor (TF) binding motifs (Stojnic and
Diez, 2018), although multiple CpGs overlapped TF binding sites for TFs
with a role in early development, such as TFAP2C (Sharma et al., 2016)
overlapping cg27266479 mapping to H6PD, and RAX (Bennett et al.,
2008) overlapping cg16771467 and mapping to ATP8B1. Look-up of the
19 CpGs in reference data (Bonder et al., 2017) uncovered no link be-
tween DNAm and gene expression in adult blood.
We measured DNAm in cord blood and average DNAm levels
may vary between tissues, but still reflect variation in other tissues
(Slieker et al., 2013). There was little to no correlation of methylation
at the 19 CpGs between adult whole blood and tissues from 16
cadavers (Slieker et al., 2013; Relton et al., 2015), with the notable ex-
ception of cg14560133 (SHANK1, b ¼ 1.42% (SE¼ 0.3%), P¼ 2.1 
106), which showed moderate correlation with 5/8 tissues
(rho> 0.53, P< 0.04, Fig. 2). The three CpG dinucleotides at gamma-
aminobutyric acid receptor subunit beta-3 (GABRB3) (cg01251603,
cg15066197, cg14859324), a gene active in the brain, showed weak to
moderate correlation between adult blood and four brain regions
(rho¼ 0.39–0.62, P< 0.001, N¼ 71–74) in another reference dataset
(Hannon et al., 2015).
Imprinted regions and meta-stable
epialleles
Multiple candidate gene studies have looked at DNAm or gene ex-
pression differences of imprinted genes between ART and MUC with
mixed results. Therefore, we looked at 374 CpGs on the 450k array
known to overlap imprinted differentially methylated regions (Yuen
et al., 2011). There was no overlap with the CpGs showing a (sugges-
tive) association with ART in our study (P< 105, N¼ 37). These 374
CpGs were distributed over 59 regions. There was no difference in
DNAm between MUC and ART infants when we tested each of these
59 regions (PFDR > 0.86). Similarly, so-called meta-stable epialleles
(MEs) are hypothesized to be especially sensitive to the early prenatal
environment (Kessler et al., 2018). There were 187 CpGs overlapping
MEs, none of which were associated with ART (PFDR > 0.06).
Prior studies
We cross-referenced our results with those from prior studies on one
form of ART. The sole region associated with IVF in the methylated
DNA immunoprecipitation sequencing study from Castillo-Fernandez
et al. (2017) was not covered by our genome-scale screen with the
............................................................................................................................................................................................................................
Table II Results of the ART epigenome-wide association study.







cg27266479 chr1:9294882 32.8 (1.9) H6PD 0 1.94 (0.27) 1.00 3.18e13 8.28E08
cg04811592 chr3:69834386 89.6 (1.6) MITF 0 0.99 (0.21) 0.62 1.59e06 0.039
cg24959663 chr5:10578618 71.2 (5.2) ANKRD33B 0 3.91 (0.54) 0.74 3.75e13 8.28E08
cg22916646 chr5:162672583 69.0 (2.6) – – 2.18 (0.36) 0.83 1.22e09 1.08E04
cg01500567 chr6:44355777 4.2 (0.6) CDC5L 0 0.48 (0.1) 0.74 5.46e07 0.020
cg00478390 chr7:150703765 89.4 (2.1) NOS3 0 0.92 (0.19) 0.44 7.37e07 0.024
cg03207674 chr7:1523569 92.7 (1.1) INTS1 0 0.72 (0.14) 0.64 1.92e07 9.43E03
cg17123384 chr7:83379152 82.0 (4.0) – – 2.78 (0.51) 0.70 6.39e08 3.53E03
cg19347588 chr10:3868336 92.9 (1.2) KLF6 40862 0.81 (0.16) 0.66 4.49e07 0.018
cg07569385 chr13:20766226 10.8 (2.3) GJB2 0 1.53 (0.31) 0.68 1.24e06 0.036
cg06485032 chr13:22615064 71.4 (5.3) AK054845 0 3.47 (0.67) 0.65 2.59e07 0.011
cg13051607 chr15:22956714 86.1 (2.1) CYFIP1 0 1.39 (0.24) 0.65 1.15e08 7.24 E04
cg01251603 chr15:26874098 76.7 (5.3) GABRB3 0 4.89 (0.8) 0.92 1.18e09 1.08 E04
cg15066197 chr15:26874202 85.8 (4.8) GABRB3 0 4.71 (0.79) 0.99 2.48e09 1.83 E04
cg14859324 chr15:26874363 92.3 (2.9) GABRB3 0 2.26 (0.46) 0.78 7.68e07 0.024
cg06450634 chr16:30430044 67.0 (3.3) ZNF771 0 3.26 (0.46) 0.98 2.15e12 3.17E07
cg08783253 chr17:40996565 73.7 (5.3) AOC2 42 2.93 (0.61) 0.55 1.48e06 0.038
cg16771467 chr18:55315872 98.5 (0.2) ATP8B1 0 0.11 (0.02) 0.55 1.34e06 0.037
cg14560133 chr19:51199453 28.8 (2.0) SHANK1 0 1.42 (0.3) 0.71 2.07e06 0.048
The results of the ART versus MUC epigenome-wide association study are ordered on genomic location (hg19). A negative estimate means a lower DNAm in the ART group.
1Mean methylation (beta value*100) and SD.
2Nearest gene within 100k nucleotides and the distance to the transcription start site. Human Genome Nomenclature consortium approved gene names: H6PD, hexose-6-phosphate dehy-
drogenase/glucose 1-dehydrogenase; MITF, melanocyte inducing transcription factor; ANKRD33B, ankyrin repeat domain 33B; CDC5L, cell division cycle 5 like; NOS3, nitric oxide syn-
thase 3; INTS1, integrator complex subunit 1, KLF6, Kruppel-like factor 6; GJB2, gap junction protein beta 2; AK054845, transcript for long intergenic non-protein coding RNA 540;
CYF1P1, cytoplasmic FMR1-interacting protein 1; GABRB3, Gamma-Aminobutyric Acid Type A Receptor Subunit Beta3; ZNF771, Zinc Finger Protein 771; AOC2, Amine Oxidase
Copper Containing 2; ATP8B1, ATPase Phospholipid Transporting 8B1; SHANK1, SH3 and Multiple Ankyrin Repeat Domains 1.
3Estimate and SE followed by columns with the effect size (in SDs) and P-value, with and without false discovery rate (FDR) correction of the estimate of ART versus MUC in the
model: Beta  ART (yes/no) þ height on micro-array slide þ scan batch þ bisulfite plate þ sex þ CD4T þ CD8T þ Mono þ Bcell þ NK þ Gran þ nRBC. NK: natural killer cells;
nRBC, nucleated red blood cells, Mono: monocytes, Gran: granulocytes.












































..450k array. Next, El Hajj et al. (2017) found 4730 CpG dinucleotides
associated with ICSI after FDR adjustment (which were not available
from their article) of which two regions, out of five regions selected
for validation with pyrosequencing, were validated in an additional
sample. The seven CpGs in these two regions, which cover the proxi-
mal promoters of ATG4C and SNORD114-9, were not associated with
ART in our study (P> 0.23) or with ICSI only (post-hoc Tukey’s test:
P> 0.40).
Using the 850k array, Novakovic et al. (2019) identified 2340
CpG dinucleotides at which DNAm in Guthrie card blood was asso-
ciated with IVF and GIFT coupled with IUI, 1228 of which were cov-
ered in our 450k study. Of these, 38 were nominally associated
(P< 0.05) and with the same direction of effect in our study. This
decreased to 12 CpGs when we tested for DNAm differences be-
tween MUC and IVF only. Novakovic et al. (2019) also identified
three differentially methylated regions where the difference in meth-
ylation associated with IVF remained in an adult sample. CpG dinu-
cleotides at CHRNE (chr17:4803506–4805392), PRSS16
(chr6:27185896–27186199) and TMEM18 (chr2:731073–732037)
showed a similar direction of effect in our study as that of
Novakovic et al. (2019) and the association was almost nominally
significant for PRSS16 (cg10279314: b¼ 2.3% (SE¼ 1.2%),
P¼ 0.057, cg09395805: b ¼ 3.1 (SE¼ 1.6), P¼ 0.049, cg07555084:
b ¼ 2.2 (SE ¼1.2), P¼ 0.074, Supplementary Table SIV).
Discussion
We identified 19 CpGs at which DNAm was associated with ART
and the association extended to neighboring CpG dinucleotides at
AK054845 and GABRB3. We found no indication for a disparity be-
tween IVF or ICSI on DNAm patterns. The associations were robust
to adjustment for cellular heterogeneity and maternal characteristics,
and did not overlap with those loci associated with other common
prenatal exposures. We found no evidence that imprinted loci and
MEs are especially sensitive to ART. The 19 CpGs can be annotated
to genes with a role in the brain or the plethora of conditions that can
be linked to subfertility, but we found no clear functional implications
of the variation in DNAm at these 19 CpGs.
The 19 CpG dinucleotides could be mapped to 15 genes. Four of
the 19 were located in a proximal promoter and here the neighboring
CpG dinucleotides were also nominally associated with ART. In other
cases, the associations were either limited to one CpG dinucleotide,
which may stem from the sparse coverage of the 450K array across
the methylome and in other cases is consistent with the fact that
DNAm acts through the altering of the binding potential of a specific
TFBS (Bonder et al., 2017). Indeed, none of the CpGs were located in
a CpG island, which is consistent with data from other exposures
showing that associations between DNAm and prenatal and/or envi-
ronmental conditions are enriched at regulatory regions such as
Figure 1. Manhattan plot of the epigenome-wide association study for ART status. A Manhattan plot showing the –log10 P-values (y-
axis) for the association of DNAm at individual CpG dinucleotides across the 22 autosomal chromosomes (x-axis). CpG dinucleotides 5kb up- and
downstream of the lead association have been colored in the same color as the lead association. H6PD, hexose-6-phosphate dehydrogenase/glucose
1-dehydrogenase; MITF, melanocyte inducing transcription factor; ANKRD33B, ankyrin repeat domain 33B; CDC5L, cell division cycle 5 like; NOS3, ni-
tric oxide synthase 3; INTS1, integrator complex subunit 1; KLF6, Kruppel-like factor 6; GJB2, gap junction protein beta 2; AK054845, transcript for
long intergenic non-protein coding RNA 540; CYF1P1, cytoplasmic FMR1-interacting protein 1; GABRB3, Gamma-Aminobutyric Acid Type A
Receptor Subunit Beta3; ZNF771, Zinc Finger Protein 771; AOC2, Amine Oxidase Copper Containing 2; ATP8B1, ATPase Phospholipid Transporting
8B1; SHANK1, SH3 and Multiple Ankyrin Repeat Domains 1; DNAm, DNA methylation.































































































enhancers and CpG poor promoters that show intermediate levels of
methylation (Tobi et al., 2014).
The mean absolute differences between MUC and ART are
small from a molecular perspective (b¼ 0.48–4.89%), while ef-
fect sizes were medium to large effect from an epidemiological
perspective (0.44–1.00 SD). This is in line with results from
(meta-)analyses on other prenatal exposures such as prenatal
smoking (Joubert et al., 2016b), folate use (Joubert et al., 2016a),
famine (Tobi et al., 2018) and hypertension and pre-eclampsia
(Kazmi et al., 2019). Such differences are thought to exert an ef-
fect through the modulation of gene networks (Stoger, 2008; Jiao
et al., 2014) or to mark other larger molecular differences in a
regulatory region, such as in histone modifications, and animal
experimental data suggest that small absolute differences in
methylation of medium effect size may still exert a measurable
effect on gene expression (Lillycrop et al., 2008).
Several of the CpGs can be linked to genes with a role in brain func-
tion and/or development. ZNF771 (cg06450634) has been identified
as a driving factor behind a large gene network in the brain (Maulik
et al., 2018) and CYFIP1 (cg13051607) (Hsiao et al., 2016), GABRB3
(cg01251603, cg15066197, cg14859324) (Tanaka et al., 2012) and
SHANK1 (cg14560133) (Sungur et al., 2018) are all autism spectrum
disorder candidate genes, a phenotype tentatively associated with ART
(Liu et al., 2017). Although these observations are of potential interest,
it should be noted that only for CpGs near GABRB3 the DNAm level
correlated between blood and brain regions (Hannon et al., 2015) and
for none of the CpGs was DNAm level associated with expression of
the nearest gene in whole blood data. In addition, several CpG dinu-
cleotides can be linked to genes connected to the plethora of condi-
tions that can be linked to subfertility. H6PD (cg27266479) is a
candidate gene for polycystic ovary syndrome (Martı́nez-Garcı́a et al.,
2012). INTS1 (cg03207674) has a crucial role in the developing blasto-
cyst, as inhibition of INTS1 function causes growth arrest (Hata and
Nakayama, 2007). NOS3 (cg00478390) knockout mice are used as an
in vivo model of (recurrent) embryo loss, as nitric oxide metabolism
plays an important role in implantation (Pallares and Gonzalez-Bulnes,
2010). Although the function of the genes is arguably plausible in the
context of ART, we could not detect a correlation between DNAm
level in blood and other tissues at these CpGs, although the available
reference data does not have tissues relevant to subfertility (e.g. ovary,
placenta and uterus).
The latter may hint that the various medical reasons for ART may
underlie the associations, rather than the ART process itself, which is
a key question in the study of ART (Luke et al., 2016). We employed
DAG (Krieger and Davey Smith, 2016) and DAG indicated that ascer-
tainment of a direct effect is possible with a small minimal adjustment
set (Supplementary Figs S6 and S7). There was little to no effect on
the effect estimates from adjustment for various maternal characteris-
tics, gestational age and the number of years until pregnancy (as a
proxy for in-/subfertility). In addition, we did not find any evidence for
different or stronger effects of ICSI on DNAm as has been hypothe-
sized (Loke and Craig, 2016) and the fertility clinics from which we
recruited all used the same culture media for ICSI and IVF. These last
two items might argue that not the (reasons for) infertility but the
ART process itself may explain the associations.
Our analysis did not find widespread genome-wide differences like
other genome-scale studies to date (El Hajj et al., 2017; Novakovic
et al., 2019), but is consistent with a genome-scale study on only IVF
using immunoprecipitation of methylated DNA with next-generation
sequencing (Castillo-Fernandez et al., 2017). We extensively compared
individual results, as far as possible, and found little overlap. One ex-
planation is that genome-scale DNAm studies of ART to date had a
relatively low statistical power and hence a substantial false-negative
rate. This is also true for our own study, despite being one of the
larger studies to date. The field would benefit from a future meta-
analysis using ART case-control and regular (birth) cohort studies. An
alternative explanation is that the differences may also stem from the
different scope of the measurement techniques used (Castillo-
Fernandez et al., 2017) and the different sources of genomic DNA
(Guthrie card versus whole cord blood) (Novakovic et al., 2019). In
addition, it is possible that different media were used between coun-
tries or that our results are different because only a small proportion
of our IVF and ICSI groups consisted of embryos that were frozen
Figure 2. Correlation between adult blood DNAm and in-
ternal tissues. The spearman correlation plotted for eight tissues
from the body (N ¼ 16, P < 0.1) and four from the brain (N > 71,
P < 0.01) in colors ranging from bright red (rho ¼ 1.0) to dark blue
(rho ¼ 1.0). The light gray lines along the rows identify the three CpG
dinucleotides from the gamma-aminobutyric acid receptor subunit
beta-3 (GABRB3) region associated with ART. The light gray line run-
ning along one column denotes the separation of the two tissue refer-
ence datasets used. ‘Fat Sub’: subcutaneous fat, ‘Left Myocard’: left
myocardium, ‘Muscle Skel’: skeleton muscle, ‘prefr.cortex’: prefrontal
cortex, ‘ent.cortex’: entorhinal cortex, ‘s.t.gyrus’: superior temporal
gyrus.































































































and/or cultured extensively in comparison to other studies. We were
underpowered to test the influence of this latter aspect as most ART
procedures in our study entailed fresh embryos that were not cultured
extensively in vitro.
Our study is one of the larger genome-scale DNAm studies on ART
to date and we are the first to study both IVF and ICSI on this scale.
Nonetheless, our study has important limitations to consider. First,
DNAm is one of the drivers of cell identity (Jaenisch and Bird, 2003) and
we measured cord blood, which may be a tissue less relevant in relation
to study outcomes although it may still mark processes in relevant tissues
due to mitotic inheritance (Heijmans and Mill, 2012). We used the latest
methods to impute the seven major cell types in cord blood (Gervin
et al., 2019) and in line with an earlier report (El Hajj et al., 2017), these
imputed cell types did not differ between infants conceived with or with-
out ART and adjustment did not alter the effect estimates. However,
most of these major cell types consist of subsets of more specialized cells
(subsequently showing unique DNAm profiles at increasingly select loci)
and their influence could not be investigated. However, none of the 19
CpG dinucleotides is linked to a gene with a role in (auto)immune func-
tion or hematopoiesis. Another major driver of DNAm variation is ge-
netic variation (Bonder et al., 2017) and we did not control for genetic
variation in our analyses. DNAm of the 19 CpG dinucleotides was not
measured by probes where genetic variation influences the actual mea-
surement of DNAm (Zhou et al., 2017). A large meta-analysis has identi-
fied SNPs influencing the DNAm levels (Bonder et al., 2017) and 10 out
of the 19 CpG dinucleotides have one or more SNPs shown to influence
DNAm levels. Although the variance explained by these SNPs was small,
we cannot completely exclude the possibility that (part of) the difference
in DNAm is explained by genetic variation as we have not measured
this. However, prior work on the influence of the prenatal environment
on DNAm variation shows that this effect of the prenatal environment
can be completely independent of, and additive to, the influence of local
genetic variation influencing DNAm at the same genomic regions (Tobi
et al., 2012). Also important is to consider the fact that an ART popula-
tion is inherently different from the general population (Luke et al., 2016).
Despite controlling for possible confounding factors, and cross-checking
our results with other EWAS on prenatal complications/exposures, unre-
solved confounding remains a possibility. Our study differs from some of
the earlier ART studies, which is useful for triangulation between studies
(Lawlor et al., 2016), as our control group has a higher rather than a
lower SES, as is normal in most of studies on ART.
The data presented here showcases modest and specific DNAm dif-
ferences that are associated with ART, of which the functional rele-
vance in adult tissues is unknown. We did not find any difference in
DNAm patterns between IVF and ICSI. Our study found little evi-
dence for the hypothesis that ART, be it IVF or ICSI, leads to wide-
spread disturbances of DNAm patterns or for the hypothesis that ICSI
has a different/larger relation with DNAm patterns. Our findings war-
rant cautious interpretation given the sample size and the subsequent
low power due to the number of tests performed, the tissue studied
and the unknown functional consequences of the identified DNAm
differences.
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Küpers LK, Monnereau C, Sharp GC, Yousefi P, Salas LA, Ghantous
A, Page CM, Reese SE, Wilcox AJ, Czamara D et al. Meta-analysis
of epigenome-wide association studies in neonates reveals wide-
spread differential DNA methylation associated with birthweight.
Nat Commun 2019;10:1893.
Lawlor DA, Tilling KDavey Smith G. Triangulation in aetiological epi-
demiology. Int J Epidemiol 2016;45:1866–1886.
Lazaraviciute G, Kauser M, Bhattacharya S, Haggarty P, Bhattacharya
S. A systematic review and meta-analysis of DNA methylation lev-
els and imprinting disorders in children conceived by IVF/ICSI
compared with children conceived spontaneously. Hum Reprod
Update 2014;20:840–852.
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